Labat Africa Ltd - Asset Resilience Ratio

Latest as of May 2024: 0.02%

Labat Africa Ltd (LAB) has an Asset Resilience Ratio of 0.02% as of May 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read LAB current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

ZAC26.00K

≈ $13.82 USD Cash + Short-term Investments

Total Assets

ZAC123.39 Million

≈ $65.58K USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2002–2024)

This chart shows how Labat Africa Ltd's Asset Resilience Ratio has changed over time. See LAB net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Labat Africa Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Labat Africa Ltd worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	ZAC0.00	0%
Short-term Investments	ZAC26.00K	0.02%
Total Liquid Assets	ZAC26.00K	0.02%

Asset Resilience Insights

Limited Liquidity: Labat Africa Ltd maintains only 0.02% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Labat Africa Ltd Industry Peers by Asset Resilience Ratio

Compare Labat Africa Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Zhejiang Huahai Pharmaceutical Co Ltd SHG:600521	Drug Manufacturers - Specialty & Generic	0.44%
Emcure Pharmaceuticals Ltd NSE:EMCURE	Drug Manufacturers - Specialty & Generic	1.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Ningbo Menovo Pharm Co Ltd SHG:603538	Drug Manufacturers - Specialty & Generic	2.69%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	20.24%
Hunan Warrant Pharmaceutical Co. Ltd. A SHG:688799	Drug Manufacturers - Specialty & Generic	0.40%

Annual Asset Resilience Ratio for Labat Africa Ltd (2002–2024)

The table below shows the annual Asset Resilience Ratio data for Labat Africa Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-08-31	0.02%	ZAC26.00K ≈ $13.82	ZAC123.39 Million ≈ $65.58K	+0.00pp
2023-08-31	0.02%	ZAC26.00K ≈ $13.82	ZAC132.94 Million ≈ $70.65K	+0.01pp
2022-08-31	0.01%	ZAC26.00K ≈ $13.82	ZAC207.62 Million ≈ $110.34K	+0.00pp
2021-08-31	0.01%	ZAC26.00K ≈ $13.82	ZAC222.56 Million ≈ $118.28K	-0.60pp
2019-08-31	0.62%	ZAC1.21 Million ≈ $643.58	ZAC196.53 Million ≈ $104.45K	+0.45pp
2018-08-31	0.16%	ZAC103.00K ≈ $54.74	ZAC62.90 Million ≈ $33.43K	+0.14pp
2017-08-31	0.02%	ZAC9.92K ≈ $5.27	ZAC45.85 Million ≈ $24.37K	-0.02pp
2016-08-31	0.04%	ZAC9.92K ≈ $5.27	ZAC23.53 Million ≈ $12.51K	0.00pp
2015-08-31	0.05%	ZAC10.00K ≈ $5.31	ZAC21.64 Million ≈ $11.50K	+0.00pp
2014-08-31	0.05%	ZAC9.92K ≈ $5.27	ZAC21.99 Million ≈ $11.68K	+0.01pp
2013-08-31	0.04%	ZAC9.92K ≈ $5.27	ZAC26.58 Million ≈ $14.12K	+0.02pp
2011-08-31	0.02%	ZAC10.00K ≈ $5.31	ZAC50.85 Million ≈ $27.03K	-0.36pp
2010-08-31	0.38%	ZAC179.00K ≈ $95.13	ZAC47.59 Million ≈ $25.29K	+0.06pp
2009-08-31	0.31%	ZAC179.00K ≈ $95.13	ZAC57.36 Million ≈ $30.48K	+0.15pp
2006-08-31	0.17%	ZAC350.00K ≈ $186.01	ZAC210.52 Million ≈ $111.88K	-5.41pp
2005-08-31	5.58%	ZAC9.70 Million ≈ $5.15K	ZAC173.79 Million ≈ $92.36K	-10.61pp
2004-08-31	16.19%	ZAC37.02 Million ≈ $19.67K	ZAC228.66 Million ≈ $121.52K	-4.24pp
2003-08-31	20.43%	ZAC55.39 Million ≈ $29.43K	ZAC271.12 Million ≈ $144.09K	+6.84pp
2002-08-31	13.59%	ZAC37.95 Million ≈ $20.17K	ZAC279.21 Million ≈ $148.38K	--

pp = percentage points

About Labat Africa Ltd

JSE:LAB South Africa Drug Manufacturers - Specialty & Generic

Market Cap

$3.29 Million

ZAC6.20 Billion ZAC

Market Cap Rank

#29060 Global

#210 in South Africa

Share Price

ZAC3.00

Change (1 day)

+0.00%

52-Week Range

ZAC3.00 - ZAC9.00

All Time High

ZAC155.00